Ain Holdings Inc.
Ain Holdings Inc. 9627.T Peers
See (9627.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 9627.T | $5,497.00 | -0.45% | 192.73B | 19.21 | $286.16 | +1.46% |
| 3088.T | $2,974.00 | +10.97% | 1.20T | 23.89 | $124.49 | +1.48% |
| 3349.T | $8,847.00 | -0.97% | 701.19B | 23.83 | $371.29 | +0.71% |
| 9989.T | $4,866.00 | +1.35% | 569.16B | 18.86 | $257.98 | +2.67% |
| 7649.T | $3,117.00 | +0.52% | 564.07B | 21.94 | $142.06 | +1.12% |
| 3391.T | $11,380.00 | +0.35% | 553.84B | 33.79 | $336.74 | +3.52% |
| 3141.T | $2,513.00 | +0.24% | 521.66B | 34.79 | $72.23 | +1.43% |
| 3549.T | $3,578.00 | -1.95% | 367.63B | 20.34 | $175.95 | +0.35% |
| 3148.T | $3,185.00 | +1.11% | 205.76B | 14.50 | $219.68 | +2.23% |
| 9267.T | $3,625.00 | -1.76% | 110.19B | 16.36 | $221.60 | +0.36% |
Stock Comparison
9627.T vs 3088.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3088.T has a market cap of 1.20T. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3088.T trades at $2,974.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3088.T's P/E ratio is 23.89. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3088.T's ROE of +0.10%. Regarding short-term risk, 9627.T is less volatile compared to 3088.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3349.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3349.T has a market cap of 701.19B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3349.T trades at $8,847.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3349.T's P/E ratio is 23.83. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3349.T's ROE of +0.12%. Regarding short-term risk, 9627.T is more volatile compared to 3349.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 9989.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 9989.T has a market cap of 569.16B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 9989.T trades at $4,866.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 9989.T's P/E ratio is 18.86. In terms of profitability, 9627.T's ROE is +0.07%, compared to 9989.T's ROE of +0.12%. Regarding short-term risk, 9627.T is more volatile compared to 9989.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 7649.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 7649.T has a market cap of 564.07B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 7649.T trades at $3,117.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 7649.T's P/E ratio is 21.94. In terms of profitability, 9627.T's ROE is +0.07%, compared to 7649.T's ROE of +0.11%. Regarding short-term risk, 9627.T is more volatile compared to 7649.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3391.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3391.T has a market cap of 553.84B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3391.T trades at $11,380.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3391.T's P/E ratio is 33.79. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3391.T's ROE of +0.06%. Regarding short-term risk, 9627.T is more volatile compared to 3391.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3141.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3141.T has a market cap of 521.66B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3141.T trades at $2,513.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3141.T's P/E ratio is 34.79. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3141.T's ROE of +0.06%. Regarding short-term risk, 9627.T is more volatile compared to 3141.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3549.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3549.T has a market cap of 367.63B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3549.T trades at $3,578.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3549.T's P/E ratio is 20.34. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3549.T's ROE of +0.13%. Regarding short-term risk, 9627.T is less volatile compared to 3549.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3148.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3148.T has a market cap of 205.76B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3148.T trades at $3,185.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3148.T's P/E ratio is 14.50. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3148.T's ROE of +0.11%. Regarding short-term risk, 9627.T is more volatile compared to 3148.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 9267.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 9267.T has a market cap of 110.19B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 9267.T trades at $3,625.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 9267.T's P/E ratio is 16.36. In terms of profitability, 9627.T's ROE is +0.07%, compared to 9267.T's ROE of +0.14%. Regarding short-term risk, 9627.T is less volatile compared to 9267.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3341.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3341.T has a market cap of 93.66B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3341.T trades at $3,135.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3341.T's P/E ratio is 67.19. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3341.T's ROE of +0.02%. Regarding short-term risk, 9627.T is less volatile compared to 3341.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3034.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3034.T has a market cap of 71.69B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3034.T trades at $1,909.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3034.T's P/E ratio is 16.93. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3034.T's ROE of +0.09%. Regarding short-term risk, 9627.T is less volatile compared to 3034.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 2664.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 2664.T has a market cap of 64.30B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 2664.T trades at $2,879.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 2664.T's P/E ratio is 14.70. In terms of profitability, 9627.T's ROE is +0.07%, compared to 2664.T's ROE of +0.04%. Regarding short-term risk, 9627.T is less volatile compared to 2664.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 219A.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 219A.T has a market cap of 52.59B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 219A.T trades at $2,336.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 219A.T's P/E ratio is -47.28. In terms of profitability, 9627.T's ROE is +0.07%, compared to 219A.T's ROE of -0.10%. Regarding short-term risk, 9627.T is less volatile compared to 219A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 4931.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 4931.T has a market cap of 51.87B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 4931.T trades at $2,456.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 4931.T's P/E ratio is 19.00. In terms of profitability, 9627.T's ROE is +0.07%, compared to 4931.T's ROE of +0.14%. Regarding short-term risk, 9627.T is less volatile compared to 4931.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 7679.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 7679.T has a market cap of 39.48B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 7679.T trades at $2,015.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 7679.T's P/E ratio is 10.30. In terms of profitability, 9627.T's ROE is +0.07%, compared to 7679.T's ROE of +0.12%. Regarding short-term risk, 9627.T is less volatile compared to 7679.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 8095.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 8095.T has a market cap of 19.54B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 8095.T trades at $484.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 8095.T's P/E ratio is -7.66. In terms of profitability, 9627.T's ROE is +0.07%, compared to 8095.T's ROE of -0.08%. Regarding short-term risk, 9627.T is more volatile compared to 8095.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 4350.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 4350.T has a market cap of 13.12B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 4350.T trades at $449.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 4350.T's P/E ratio is 8.13. In terms of profitability, 9627.T's ROE is +0.07%, compared to 4350.T's ROE of +0.10%. Regarding short-term risk, 9627.T is less volatile compared to 4350.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3417.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3417.T has a market cap of 12.50B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3417.T trades at $916.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3417.T's P/E ratio is 6.72. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3417.T's ROE of +0.08%. Regarding short-term risk, 9627.T is less volatile compared to 3417.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 3544.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 3544.T has a market cap of 12.44B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 3544.T trades at $904.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 3544.T's P/E ratio is 20.44. In terms of profitability, 9627.T's ROE is +0.07%, compared to 3544.T's ROE of +0.07%. Regarding short-term risk, 9627.T is more volatile compared to 3544.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 4890.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 4890.T has a market cap of 10.82B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 4890.T trades at $422.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 4890.T's P/E ratio is 26.93. In terms of profitability, 9627.T's ROE is +0.07%, compared to 4890.T's ROE of +0.29%. Regarding short-term risk, 9627.T is less volatile compared to 4890.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9627.T.
9627.T vs 2796.T Comparison
9627.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9627.T stands at 192.73B. In comparison, 2796.T has a market cap of 5.54B. Regarding current trading prices, 9627.T is priced at $5,497.00, while 2796.T trades at $488.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9627.T currently has a P/E ratio of 19.21, whereas 2796.T's P/E ratio is -6.80. In terms of profitability, 9627.T's ROE is +0.07%, compared to 2796.T's ROE of -0.11%. Regarding short-term risk, 9627.T is more volatile compared to 2796.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9627.T.